Inventor · disambiguated record
Thomas H. Marsilje
Also filed as: MARSILJE III THOMAS H · MARSILJE III THOMAS HERBERT · MARSILJE THOMAS · MARSILJE THOMAS H
17 granted patents·6 pending applications·254 citations·filing 2000–2017
94Inventor score
Top patents by PatentIndex Score
23 records- 0196US8039479B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2007·Granted Oct 18, 2011·56 cites·18 claims
- 0294US7060697B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2004·Granted Jun 13, 2006·67 cites·8 claims
- 0392US8377921B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2011·Granted Feb 19, 2013·16 cites·20 claims
- 0490US8519129B2Pyrimidine derivatives as kinase inhibitorsMARSILJE THOMAS H III·Filed 2009·Granted Aug 27, 2013·33 cites·11 claims
- 0590US8372858B2Compounds and compositions as protein kinase inhibitorsIRM LLC·Filed 2011·Granted Feb 12, 2013·14 cites·13 claims
- 0688US7070936B1Method for designing protein kinase inhibitorsUNIV NEW YORK STATE RES FOUND·Filed 2000·Granted Jul 4, 2006·28 cites·24 claims
- 0787US8399450B2Compounds and compositions as protein kinase inhibitorsMICHELLYS PIERRE-YVES·Filed 2011·Granted Mar 19, 2013·11 cites·15 claims
- 0886US7572811B2Immunosuppressant compounds and compositionsIRM LLC·Filed 2005·Granted Aug 11, 2009·11 cites·13 claims
- 0983US8592432B2Compounds and compositions as protein kinase inhibitorsCHEN BEI·Filed 2009·Granted Nov 26, 2013·6 cites·9 claims
- 1082US8957081B2Compounds and compositions as protein kinase inhibitorsMICHELLYS PIERRE-YVES·Filed 2012·Granted Feb 17, 2015·5 cites·7 claims
- 1172US8445505B2Pyrimidine derivatives as kinase inhibitorsMARSILJE III THOMAS H·Filed 2009·Granted May 21, 2013·2 cites·8 claims
- 1269US9440957B2Compounds and compositions for modulating EGFR ActivityLELAIS GERALD·Filed 2013·Granted Sep 13, 2016·3 cites·21 claims
- 1364US8859574B2Compounds and compositions as kinase inhibitorsMARSILJE THOMAS H·Filed 2013·Granted Oct 14, 2014·1 cites·8 claims
- 1463US2015105390A1Compounds and compositions as protein kinase inhibitorsMICHELLYS PIERRE-YVES·Filed 2014·Application pending·0 cites
- 1561US7375125B2Melanocortin-4 receptor binding compounds and methods of use thereofORE PHARMACEUTICALS INC·Filed 2003·Granted May 20, 2008·1 cites·30 claims
- 1649US8440681B22-biphenylamino-4-aminopyrimidine derivatives as kinase inhibitorsMARSILJE THOMAS H·Filed 2008·Granted May 14, 2013·0 cites·7 claims
- 1745US2008287516A1Phenyl-Substituted PyrrolidonesIRM LLC·Filed 2006·Application pending·0 cites
- 1844US7816542B2Compounds and compositions as TPO mimeticsIRM LLC·Filed 2006·Granted Oct 19, 2010·0 cites·6 claims
- 1942US8153671B2Heterotetracyclic compounds as TPO mimeticsALPER PHILLIP B·Filed 2006·Granted Apr 10, 2012·0 cites·10 claims
- 2040US2013338152A1Fluorophenyl bicyclic heteroaryl compoundsCHEN BEI·Filed 2012·Application pending·0 cites
- 2138US2019167694A1New therapeutics usesNOVARTIS AG·Filed 2017·Application pending·0 cites
- 2237US2012289501A1Benzene-fused 6-membered oxygen-containing heterocyclic derivatives of bicyclic heteroarylsCHEN BEI·Filed 2010·Application pending·0 cites
- 2336US2012165310A1Ether derivatives of bicyclic heteroarylsCHEN BEI·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →